94 related articles for article (PubMed ID: 32179449)
1. Improved survival in patients with head and neck cancer treated in higher volume centres: A population-based study in Belgium.
Leroy R; Silversmit G; Stordeur S; De Gendt C; Verleye L; Schillemans V; Savoye I; Van Eycken L; Deron P; Hamoir M; Vermorken J; Grégoire V; Nuyts S
Eur J Cancer; 2020 May; 130():81-91. PubMed ID: 32179449
[TBL] [Abstract][Full Text] [Related]
2. Association between hospital volume and outcomes in invasive ovarian cancer in Belgium: A population-based study.
Savoye I; Silversmit G; Bourgeois J; De Gendt C; Leroy R; Peacock HM; Stordeur S; de Sutter P; Goffin F; Luyckx M; Orye G; Van Dam P; Van Gorp T; Verleye L
Eur J Cancer; 2023 Dec; 195():113402. PubMed ID: 37922631
[TBL] [Abstract][Full Text] [Related]
3. Head and Neck Cancer in Belgium: Quality of Diagnostic Management and Variability Across Belgian Hospitals Between 2009 and 2014.
Leroy R; De Gendt C; Stordeur S; Schillemans V; Verleye L; Silversmit G; Van Eycken E; Savoye I; Grégoire V; Nuyts S; Vermorken J
Front Oncol; 2019; 9():1006. PubMed ID: 31649876
[No Abstract] [Full Text] [Related]
4. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
5. Patterns and quality of care for head and neck cancer in Belgium: A population-based study.
Verleye L; De Gendt C; Leroy R; Stordeur S; Schillemans V; Savoye I; Silversmit G; Van Eycken L; Daisne JF; Nuyts S; Vermorken J; Grégoire V
Eur J Cancer Care (Engl); 2021 Sep; 30(5):e13454. PubMed ID: 33890328
[TBL] [Abstract][Full Text] [Related]
6. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
[TBL] [Abstract][Full Text] [Related]
7. Association of Nonsteroidal Anti-inflammatory Drug Use With Survival in Patients With Squamous Cell Carcinoma of the Head and Neck Treated With Chemoradiation Therapy.
Iovoli AJ; Hermann GM; Ma SJ; Platek AJ; Farrugia MK; Yau E; Wooten KE; Arshad H; Gupta V; Kuriakose MA; Hicks WL; Singh AK
JAMA Netw Open; 2020 Jun; 3(6):e207199. PubMed ID: 32602907
[TBL] [Abstract][Full Text] [Related]
8. Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
David JM; Ho AS; Luu M; Yoshida EJ; Kim S; Mita AC; Scher KS; Shiao SL; Tighiouart M; Zumsteg ZS
Cancer; 2017 Oct; 123(20):3933-3942. PubMed ID: 28640546
[TBL] [Abstract][Full Text] [Related]
9. Prediction of survival in patients with head and neck cancer.
Baatenburg de Jong RJ; Hermans J; Molenaar J; Briaire JJ; le Cessie S
Head Neck; 2001 Sep; 23(9):718-24. PubMed ID: 11505480
[TBL] [Abstract][Full Text] [Related]
10. Survival Patterns in Elderly Head and Neck Squamous Cell Carcinoma Patients Treated With Definitive Radiation Therapy.
Sommers LW; Steenbakkers RJHM; Bijl HP; Vemer-van den Hoek JGM; Roodenburg JLN; Oosting SF; Halmos GB; de Rooij SE; Langendijk JA
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):793-801. PubMed ID: 28476434
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment oral hygiene habits and survival of head and neck squamous cell carcinoma (HNSCC) patients.
Friemel J; Foraita R; Günther K; Heibeck M; Günther F; Pflueger M; Pohlabeln H; Behrens T; Bullerdiek J; Nimzyk R; Ahrens W
BMC Oral Health; 2016 Mar; 16():33. PubMed ID: 26969620
[TBL] [Abstract][Full Text] [Related]
12. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
13. The impact of comorbidity on outcome in 12 623 Danish head and neck cancer patients: a population based study from the DAHANCA database.
Bøje CR; Dalton SO; Grønborg TK; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Overgaard J
Acta Oncol; 2013 Feb; 52(2):285-93. PubMed ID: 23320773
[TBL] [Abstract][Full Text] [Related]
14. Volume-outcome relationships for head and neck cancer surgery in a universal health care system.
Eskander A; Irish J; Groome PA; Freeman J; Gullane P; Gilbert R; Hall SF; Urbach DR; Goldstein DP
Laryngoscope; 2014 Sep; 124(9):2081-8. PubMed ID: 24706437
[TBL] [Abstract][Full Text] [Related]
15. High surgical volume is associated with improved survival in head and neck cancer.
Rygalski CJ; Huttinger ZM; Zhao S; Brock G; VanKoevering K; Old MO; Teknos TN; Rocco JW; Puram SV; Seim NB; Swendseid B; Haring CT; Eskander A; Kang SY
Oral Oncol; 2023 Mar; 138():106333. PubMed ID: 36746098
[TBL] [Abstract][Full Text] [Related]
16. Measuring Institutional Quality in Head and Neck Surgery Using Hospital-Level Data: Negative Margin Rates and Neck Dissection Yield.
Schoppy DW; Rhoads KF; Ma Y; Chen MM; Nussenbaum B; Orosco RK; Rosenthal EL; Divi V
JAMA Otolaryngol Head Neck Surg; 2017 Nov; 143(11):1111-1116. PubMed ID: 28983555
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V
Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236
[TBL] [Abstract][Full Text] [Related]
18. Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.
Machiels JP; Haddad RI; Fayette J; Licitra LF; Tahara M; Vermorken JB; Clement PM; Gauler T; Cupissol D; Grau JJ; Guigay J; Caponigro F; de Castro G; de Souza Viana L; Keilholz U; Del Campo JM; Cong XJ; Ehrnrooth E; Cohen EE;
Lancet Oncol; 2015 May; 16(5):583-94. PubMed ID: 25892145
[TBL] [Abstract][Full Text] [Related]
19. Health insurance status and survival among patients with head and neck cancer in Japan.
Takenaka Y; Yasui T; Enomoto K; Miyabe H; Morizane N; Ashida N; Shimizu K; Hirose M; Yamamoto Y; Uno A
Int J Clin Oncol; 2016 Jun; 21(3):517-22. PubMed ID: 26547423
[TBL] [Abstract][Full Text] [Related]
20. The impact of time to treatment initiation on survival from head and neck cancer in north-eastern Italy.
Polesel J; Furlan C; Birri S; Giacomarra V; Vaccher E; Grando G; Gobitti C; Navarria F; Schioppa O; Minatel E; Bidoli E; Barzan L; Franchin G
Oral Oncol; 2017 Apr; 67():175-182. PubMed ID: 28351574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
